Should diverse representation in UK clinical trials be mandatory?

 

This online event is being held by Innovative Trials, COUCH Health, and Egality HealthThree organisations who are working to improve diversity in clinical trials.

In the US, FDA guidance states that trials should recruit patients that represent the population that has the burden of disease in the real world.  We believe this should be mandatory policy for all clinical trials in the UK.

Recently, coronavirus has bought to light not only the disproportionate impact that conditions can have on certain groups, but that these groups have not been represented in the trials to find a treatment or a vaccine. 

We’re bringing together representatives from Parliament, national bodies, and industry to discuss why it isn’t policy now, what needs to be done to make it policy, and what the impact of this would be on industry, researchers, science and society.

Panellists

Chi Onuwrah

MP and Shadow Minster for Science, Research and Digital

Kate Shaw

CEO Innovative Trials

CHAIR

Ash Rishi

CEO, COUCH Health and Demand Diversity

Charles
Kwaku-Odoi

Chief Officer at Caribbean and African Health Network

Josiane
Chuisseu

Head of Sales, BioPharma at Source Bioscience

 

Sign up

To sign up for the panel discussion due to take place: 

Tuesday 10th November

12.30–14.00 GMT / 07:30–09:00 EST

Please fill out your details and you will receive a calendar invite shortly afterwards.

Your data will only be used for the purpose of Road to Equality events and communications only, which you consent to by registering for this panel.

Thought Leadership Marketing Event_Logos
Thought Leadership Marketing Event_Logos
Thought Leadership Marketing Event_Logos